Overview

Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the treatment effects of Selincro in alcohol dependent patients with liver impairment.
Phase:
Phase 4
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Ethanol
Nalmefene
Naltrexone